Adverse events after BNT162b2 do not differ for cancer patients
Feb 08, 2022
Among patients with cancer, pain at the injection site was less likely after dose 1 for those receiving active treatment.
Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
New model predicts five-year Alzheimer’s dementia risk
Oct 12, 2022
The model includes demographic information, brain imaging test results and genetic biomarkers.
Simultaneous flu vaccine, COVID-19 booster safe
Jul 21, 2022
Systemic reactions generally were mild and were slightly more likely among those receiving both vaccines compared with the COVID-19 mRNA booster alone.
Abnormal ventilatory patterns common after COVID-19 infection
Dec 09, 2021
Patients with postacute sequelae of SARS-CoV-2 infection also have circulatory impairment and myalgic encephalomyelitis/chronic fatigue.
Immunoglobulin G spike receptor binding domain antibody levels were similar after the primary series and booster dose.
SARS-CoV-2 reinfection more likely in unvaccinated individuals
Aug 09, 2021
Individuals unvaccinated against COVID-19 were more likely to be reinfected in May to June 2021 after prior infection in 2020.
Almost 30 percent of COVID-19 patients develop ‘long COVID’
May 02, 2022
Factors independently associated with PASC include hospitalization for COVID-19, having diabetes and higher body mass index.
Concerns raised about COVID-19 chronic olfactory dysfunction
Nov 19, 2021
“These data suggest an emerging public health concern of OD and the urgent need for research that focuses on treating COVID-19 COD,” the authors wrote.
mRNA-1273 continues to be efficacious at five months
Sep 27, 2021
The efficacy of mRNA-1273, the Moderna vaccine, was 93.2% for preventing COVID-19 illness and 98.2% for preventing severe COVID-19.